 |
| Issue 7, April 2007
|
Dear Shareholders
Welcome to the latest edition of Apollo Life, our regular newsletter to keep shareholders informed about our latest developments. If you would like any further information, please contact us.
If you would like any further information, please contact us.
Regards
John Priest - CEO |
|
|
 |
Apollo leads the way with revolutionary oral insulin delivery
The global market for diabetes therapies is worth a massive US$18 billion annually. In Australia, the government spends more than $135m on the PBS to supply injectable insulin to people with diabetes. Apollo is poised to revolutionise things for people with diabetes with its groundbreaking patented technology that protects insulin from being broken down in the stomach, enabling it to reach the liver, where it can do its work. |
|
|
|
Apollo flies the flag for Australia at BIO in the US
At next month’s (May) BIO2007 in Boston Apollo Life Sciences will be a key component of the Australian delegation of more than 30 companies attending the event. Apollo will exhibit in the Australian section of the exhibitor’s pavilion. |
|
Breakthrough in blood research confirms Apollo is on the right track
European scientists say they've created a technique to convert all donated blood into Group O, which can be safely given to anyone. The new groundbreaking research has implications for the work being done by Apollo researchers, with both groups essentially showing that the manipulation of sugars on proteins can reduce the risk of immune rejection. |
|
Arthritis is crippling the economy
Increasing rates of arthritis among Australians could cripple the nation's economy, with the financial costs to the nation estimated to be over $20 billion a year. National Arthritis Week, in early April, focused on the financial as well as the personal costs of this disease. It underscored the significance of Apollo's recent major announcement - the development of an oral treatment for arthritis. |
|
| Click here to subscribe |
 |
| www.apollolifesciences.com |